540 Rapid response in PASI, sPGA, and BSA measures for patients with moderate-to-severe plaque psoriasis with ixekizumab
Leonardi, C., Burge, R., See, K., Shrom, D., Guo, J., McKean-Matthews, M., Amato, D., Gallo, G., Gooderham, M.Volume:
139
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2019.03.616
Date:
May, 2019
File:
PDF, 199 KB
english, 2019